Home
>
USA
>
Investors
> News Releases
Print Page
Email Page
RSS Feeds
Email Alerts
IR Contacts
News Releases
Receive Email Alerts
|
RSS Feeds
Keyword Search
2010
|
2009
Date
Title
09/03/10
HeartWare Receives Second Patient Allotment Under Continued Access Protocol for Pivotal U.S. Bridge-To-Transplant Clinical Trial
08/05/10
HeartWare International Reports Second Quarter 2010 Revenues of $9.8 Million; Compared to $3.0 Million in Second Quarter 2009
08/04/10
HeartWare to Present at The Canaccord Genuity 30th Annual Growth Conference
07/29/10
HeartWare to Present at the Wedbush Securities 2010 Life Sciences Best Ideas Conference
07/27/10
HeartWare to Report Financial Results for Second Quarter of 2010
06/24/10
HeartWare Announces Board Succession
06/17/10
HeartWare to Present at the Wells Fargo Securities 2010 Healthcare Conference
06/14/10
HeartWare Receives Conditional FDA Approval to Commence Pivotal Destination Therapy Clinical Trial in the U.S.
05/06/10
HeartWare to Present at Bank of America Merrill Lynch Health Care Conference in New York
05/03/10
HeartWare International Reports First Quarter 2010 Revenues of $10.7 Million; Compared With $1.5 Million In First Quarter 2009
04/26/10
HeartWare Initiates Repairs and Partial Recall of Controllers
04/23/10
HeartWare Data From First 100 Patients in International Clinical and Commercial Experience Shows 90% Survival at 180 Days
04/12/10
HeartWare to Report Financial Results for First Quarter of 2010
04/07/10
HeartWare Receives FDA Approval of Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial
03/11/10
HeartWare to Present at the Barclays Capital 2010 Global Healthcare Conference
03/04/10
HeartWare to Present at the Roth Capital Partners OC Growth Stock Conference
02/22/10
HeartWare International Reports Fourth Quarter Revenues of $12.2 Million; Full Year 2009 Revenues of $24.2 Million
02/22/10
HeartWare Announces Early Conclusion of Enrollment for U.S. Bridge-to-Transplant Clinical Trial
02/08/10
HeartWare to Report 2009 Fourth Quarter and Year-End Financial Results
02/02/10
HeartWare International, Inc. Announces Completion of Public Offering of Common Stock
01/27/10
HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
01/26/10
HeartWare International, Inc. Announces Commencement of Public Offering of Common Stock
01/06/10
HeartWare to Present at J.P. Morgan Healthcare Conference in San Francisco
11/25/09
HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City
11/06/09
HeartWare to Present at Upcoming Investment Conferences in November
11/04/09
HeartWare International Reports Third Quarter Revenues of $7.5 Million
10/29/09
Advance Notice of Q3 Earnings Call
10/05/09
U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
09/01/09
HeartWare International, Inc. Temporary Suspension of Trading
08/20/09
HeartWare International Surpasses 50 Implants in the US
08/17/09
HeartWare International, Inc. Closes US$60 Million Financing
08/11/09
HeartWare to Present at Canaccord Adams 29th Annual Global Growth Conference
08/10/09
HeartWare International, Inc. Announces US$55 Million Financing
07/31/09
Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction
07/29/09
U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International
05/12/09
HeartWare to Present at Eighth Annual JMP Securities Research Conference
04/24/09
HeartWare International Clinical Trial Shows 90% Survival at 180 Days
Copyright © HeartWare International, Inc.
Legal Disclaimer
|
Contact Us